icotec received FDA 510(k) clearance to market the VADER® Pedicle System for use with or without bone cement.
VADER is intended to restore spinal integrity, even in the absence of fusion, for a limited time period in patients with advanced-stage tumors in the thoracic and lumbar spine in whom life expectancy, prior to oncological treatment, is of insufficient duration to permit fusion.
The screw’s fenestration allows for bone cement augmentation to increase stability in patients with compromised bone.
“We are so proud to present today the VADER® product family which represents our continued commitment to develop and commercialize spinal implants made from our radiotransparent, nonmetallic BlackArmor® material that produces minimal image artifact while eliminating shielding and scattering of radiation during oncology treatments,” said Roger Stadler, CEO of icotec.
icotec received FDA 510(k) clearance to market the VADER® Pedicle System for use with or without bone cement.
VADER is intended to restore spinal integrity, even in the absence of fusion, for a limited time period in patients with advanced-stage tumors in the thoracic and lumbar spine in whom life expectancy, prior to oncological...
icotec received FDA 510(k) clearance to market the VADER® Pedicle System for use with or without bone cement.
VADER is intended to restore spinal integrity, even in the absence of fusion, for a limited time period in patients with advanced-stage tumors in the thoracic and lumbar spine in whom life expectancy, prior to oncological treatment, is of insufficient duration to permit fusion.
The screw’s fenestration allows for bone cement augmentation to increase stability in patients with compromised bone.
“We are so proud to present today the VADER® product family which represents our continued commitment to develop and commercialize spinal implants made from our radiotransparent, nonmetallic BlackArmor® material that produces minimal image artifact while eliminating shielding and scattering of radiation during oncology treatments,” said Roger Stadler, CEO of icotec.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
